CLOs on the Move

Centric Business Systems

www.centricbiz.com

 
Centric Business Systems offers document management solutions for businesses. We provide state of the art printers & copiers in Baltimore, MD, PA, DC, DE, VA.
  • Number of Employees: 250-1000
  • Annual Revenue: $50-100 Million
  • www.centricbiz.com
  • 10702, Red Run Boulevard
    Owings Mills, MD USA 21117
  • Phone: 877.902.3301

Executives

Name Title Contact Details

Similar Companies

Mytec Solutions

Mytec Solutions is a leading managed IT service provider. Let us remove the headaches of maintaining, upgrading, and supporting your critical business technologies. We also provide computer repair and sales, website and email hosting solutions as well ...

Oracle

Oracle Corporation is an American multinational computer technology corporation headquartered in Austin, Texas.

Flashpoint

We strive to empower our customers to make better decisions in support of their business or mission by gathering the most salient data publicly available on the internet and providing meaningful, timely, relevant, and actionable insights through a fusion of technology and subject matter expertise. Our ultimate goal is to make the world a safer place by empowering people and organizations everywhere to detect, understand, and mitigate the risks that matter to them the most.

Envision Technology Advisors,

Envision Technology Advisors is a business and technology consulting services company that specializes in digital transformation, cybersecurity, cloud and managed services, virtualization, network and infrastructure consulting, website design and devel...

Kapost

Juventas Therapeutics is a private clinical-stage company developing novel therapies for ischemic cardiovascular disease. The company`s lead product` JVS-100` is a non-viral plasmid that encodes for stromal cell-derived factor-1 (SDF-1). SDF-1 has been shown to significantly increase end-organ function following tissue injury by promoting cell survival` recruiting endogenous stem cells to the damaged region` and promoting new blood vessel growth. The SDF-1 repair pathway is well conserved throughout end-organ systems providing the opportunity to impact a broad range of diseases. Target cardiovascular clinical indications address large markets with high unmet medical need and significant market potential. Juventas is currently enrolling multiple clinical trials to test therapy efficacy in heart failure and critical limb ischemia patients.